Episode Details
Back to EpisodesGame Changer: Are CGRP Inhibitors the New First Line for Migraine Prevention?
Episode 502
Published 1 year, 3 months ago
Description
Drs. VanderPluym and Starling review the updated position statement from the American Headache Society indicating that CGRP-targeting migraine therapies should be considered as a first-line option.